| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |